My NCBI | Sign In
RSS Settings
  • Search: Arpino G[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance.

    Arpino G, Wiechmann L, Osborne CK, Schiff R.

    Endocr Rev. 2008 Apr;29(2):217-33. Epub 2008 Jan 23. Review.PMID: 18216219 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.

    Arpino G, Gutierrez C, Weiss H, Rimawi M, Massarweh S, Bharwani L, De Placido S, Osborne CK, Schiff R.

    J Natl Cancer Inst. 2007 May 2;99(9):694-705.PMID: 17470737 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

    Schiff R, Massarweh SA, Shou J, Bharwani L, Arpino G, Rimawi M, Osborne CK.

    Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:10-20. Review.PMID: 16273359 [PubMed - indexed for MEDLINE]Related articles

    4.

    Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.

    Osborne CK, Schiff R, Arpino G, Lee AS, Hilsenbeck VG.

    Breast. 2005 Dec;14(6):458-65. Epub 2005 Oct 19. Review.PMID: 16236516 [PubMed - indexed for MEDLINE]Related articles

    5.

    Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.

    Cui X, Schiff R, Arpino G, Osborne CK, Lee AV.

    J Clin Oncol. 2005 Oct 20;23(30):7721-35. Review.PMID: 16234531 [PubMed - indexed for MEDLINE]Related articles

    6.

    Premalignant and in situ breast disease: biology and clinical implications.

    Arpino G, Laucirica R, Elledge RM.

    Ann Intern Med. 2005 Sep 20;143(6):446-57.PMID: 16172443 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

    J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.PMID: 16145046 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.

    De Laurentiis M, Arpino G, Massarelli E, Ruggiero A, Carlomagno C, Ciardiello F, Tortora G, D'Agostino D, Caputo F, Cancello G, Montagna E, Malorni L, Zinno L, Lauria R, Bianco AR, De Placido S.

    Clin Cancer Res. 2005 Jul 1;11(13):4741-8.PMID: 16000569 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.

    Arpino G, Ciocca DR, Weiss H, Allred DC, Daguerre P, Vargas-Roig L, Leuzzi M, Gago F, Elledge R, Mohsin SK.

    Breast Cancer Res Treat. 2005 Jul;92(1):69-75.PMID: 15980993 [PubMed - indexed for MEDLINE]Related articles

    10.

    Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

    Arpino G, Weiss HL, Clark GM, Hilsenbeck SG, Osborne CK.

    J Clin Oncol. 2005 Jul 20;23(21):4687-94. Epub 2005 Apr 18.PMID: 15837971 [PubMed - indexed for MEDLINE]Related articles

    11.

    HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.

    Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, Elledge RM.

    Clin Cancer Res. 2004 Sep 1;10(17):5670-6.PMID: 15355892 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Lobular neoplasia on core-needle biopsy--clinical significance.

    Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM.

    Cancer. 2004 Jul 15;101(2):242-50.PMID: 15241819 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

    Arpino G, Bardou VJ, Clark GM, Elledge RM.

    Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.PMID: 15084238 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.

    Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM.

    J Clin Oncol. 2003 May 15;21(10):1973-9.PMID: 12743151 [PubMed - indexed for MEDLINE]Related articles

    15.

    Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer.

    Arpino G, Nair Krishnan M, Doval Dinesh C, Bardou VJ, Clark GM, Elledge RM.

    Ann Oncol. 2003 Feb;14(2):233-41.PMID: 12562650 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.

    Carlomagno C, Lauria R, De Laurentiis M, Arpino G, Massarelli E, Ferrara C, Milano A, Vernaglia Lombardi A, Costanzo R, Catalano G, Bianco AR, De Placido S.

    Oncology. 2002;63(3):219-25.PMID: 12381900 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.

    Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM.

    Cancer. 2002 Apr 15;94(8):2119-27. Review.PMID: 12001107 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of the angiotensin converting enzyme inhibitor enalapril compared with diuretic therapy in elderly hypertensive patients.

    Verza M, Cacciapuoti F, Spiezia R, D'Avino M, Arpino G, D'Errico S, Sepe J, Varricchio M.

    J Hypertens Suppl. 1988 Nov;6(1):S97-9.PMID: 2851039 [PubMed - indexed for MEDLINE]Related articles

    19.

    Reliability of echocardiography in the detection of metastatic malignant pericardial masses.

    Cacciapuoti F, Arpino G, D'Avino M.

    Int J Cardiol. 1988 Jan;18(1):109-12.PMID: 3343060 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Spectroscopic examination of fluorescence of the normal human bile.]

    ARPINO G.

    Riforma Med. 1952 May 24;66(21):578. Undetermined Language. No abstract available. PMID: 14949938 [PubMed - indexed for MEDLINE]Related articles

    21.

    [Studies on spectral composition of fluorescence of blood iron in catarrhal and constitutional hemolytic jaundice.]

    ARPINO G.

    Riforma Med. 1952 Mar 22;66(12):322-3. Undetermined Language. No abstract available. PMID: 14949896 [PubMed - indexed for MEDLINE]Related articles

    22.

    [Spectrophotometric and fluorescent study on blood serum in acute yellow atrophy.]

    ARPINO G, DE LERMA B.

    Prog Med (Napoli). 1951 Nov 15;7(21):656-60. Undetermined Language. No abstract available. PMID: 14912140 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity